Assenagon Asset Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $81.9K | Sell |
|
|||||
|
2024
Q1 | $909K | Buy |
|
|||||
|
2023
Q4 | $196K | Hold |
|
|||||
|
2023
Q3 | $99.3K | Buy |
|
|||||
|
2023
Q2 | $32.7K | Hold |
|
|||||
|
2023
Q1 | $27.7K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $389K | Sell |
|
|||||
|
2021
Q2 | $631K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $315K | Sell |
|
|||||
|
2018
Q4 | $502K | Buy |
|